# Topical Cream SNG100 for Treatment in Moderate Atopic Dermatitis Subjects.

> **NCT04615962** · PHASE1 · UNKNOWN · sponsor: **Seanergy Dermatology Ltd.** · enrollment: 66 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Hydrocortisone Acetate 1% Cream
- **DRUG:** Mometasone Furoate
- **DRUG:** SNG100

## Key facts

- **NCT ID:** NCT04615962
- **Lead sponsor:** Seanergy Dermatology Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-01
- **Primary completion:** 2022-01
- **Final completion:** 2022-01
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2020-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04615962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04615962, "Topical Cream SNG100 for Treatment in Moderate Atopic Dermatitis Subjects.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04615962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*